For more information

on this study please

call +1 877-379-3718

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.

Study ID

S2WB3002

Study Title A randomised, double-blind, placebo-controlled, oral sumatriptan-controlled (100mg), three attack, parallel group study to determine the efficacy, safety and tolerability of oral naratriptan (0.1mg, 0.25mg, 1.0mg and 2.5mg) in the acute treatment of migraine headache.
Clinicaltrials.gov Identifier
Sponsor GlaxoSmithKline
Collaborators N/A
Study Recruitment Status Completed
Generic Name naratriptan
Trade Name amerge; naramig
Study Indication Migraine Disorders